Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's Disease.

Jorge Uriel Máñez-MiróFrancisco Vivancos-MatellanoFernando Alonso-FrechLydia Vela-DesojoN López ArizteguiLydia López-ManzanaresErnest BalaguerMartínez-Castrillo Juan Carlos Yolanda Herrero-InfanteCarmen Gasca-SalasMaría Isabel Morales-CasadoElena CasasAntonio HernándezIsabel PareésIciar Tegel-AyuelaRaul Martínez-FernándezPablo Martínez-Martín

Published in: Movement disorders clinical practice (2022)

OPTIMIPARK might be more sensitive than regular clinical practice in suggesting the need for a therapeutic change. Furthermore, the low and high scores identify with high accuracy well-adjusted patients and candidates for advanced therapy, respectively.

Keyphrases

clinical practice
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
mesenchymal stem cells
cell therapy
smoking cessation